Researchers continue to study how older medicines may work against cancer. Many approved drugs show activity against tumor pathways not originally targeted. This approach can shorten development time since safety profiles are already known. Studies often compare drug behavior in different cancer types. This strategy aims to expand treatment choices. It also helps lower research costs. https://www.beatcancerfoundation.org/